Early vaccine work Target Verndari as a potential partner for contract development and manufacturing services around next generation vaccine platforms, including their VaxiPatch system and microneedle delivery, leveraging their preclinical COVID-19 and flu vaccine work to expand opportunities in pandemic preparedness.

VaxiPatch tech Highlight opportunities to supply specialized materials, reagents, and analytical tools that support dermal patch formulation, vaccine stability testing, and regulatory documentation for a patch-based delivery platform.

Small team, nimble Position services for a small but strategic biotech client with a focused R&D footprint, offering flexible partnerships, rapid prototyping, and outsourced regulatory support to accelerate timelines without the overhead of larger contract organizations.

Publications as proof Leverage Verndari’s published data in Vaccine and related journals to build credibility with potential funders and partners, using the publications to support joint grant applications, co-development, or milestone-based collaboration proposals.

Napa biotech hub Leverage regional proximity to California biopharma clusters for local partnerships, pilot manufacturing collaborations, and access to ancillary services, while aligning with sustainability and local supply chain considerations to reduce risk and improve time-to-market.